Filter
29
Filtered Results: 29
Text search:
Food
and
Drugs
Authority
(FDA),
Ghana
Featured
Recommendations
3
New Publications
13
Language
Document type
No document type
17
Studies & Reports
6
Guidelines
3
Manuals
2
Strategic & Response Plan
1
Countries / Regions
Ghana
14
Nigeria
2
Nepal
1
Rwanda
1
Malawi
1
Authors & Publishers
Publication Years
Category
Guidelines
4
Drugs & Medical Equipment
4
Policies
3
Policies & Guidelines HIV & TB
2
Studies & Reports
2
Pharmacy & Technology
1
Disaster Preparedness
1
Virology
1
Statistics
1
Neurology & Psychology
1
HIV & STI
1
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
HIV testing & services
2
Country specific
2
Supporting tools
2
Falsified & Substandard
2
ART Drug Resistance
1
Policies & Programmes
1
Public Health
1
General Studies & Reports
1
Research
1
Climate & Health
1
Studies
1
Access & Strategy
1
Logistics & Supply
1
Research & Pipeline
1
Essential Medicines
1
Rational use of Medicine
1
Pharmacovigilance
1
Reports & Studies
1
Mental Disorders
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
Ghana
1
Testing Guidelines
1
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
The Ghanaian Cabinet approved the antimicrobial resistance (AMR)Policy and Implementation plan(hereafter referred to as the national action plan or NAP)in December 2017, whilst the country case study was in progress. This has set in motion the implementation phase for Ghana, which is a long awaited...
The WHO country office for Ghana, began the year 2019 with a 4-day staff retreat at the Busua Beach Resort in the Western Region from 04 to 08 March 2019. The theme for the retreat was ‘Impacting the Health and Lives of the people of Ghana through the Triple Billion Goal”. The staff outlined pri...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
Due to the anticipated significant rise in VL testing occasioned by Ghana’s adaptation of 2016 ART guidelines, it has become necessary to develop this VL scale-up and operational plan to assure complete client access to laboratory monitoring towards the achievement of the third 90 of the HIV care ...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
3rd edition
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
